A new clinical trial with lots of hope.

We went to see Dr. Haverokos at UC Health Ashutz Campus yesterday morning. I was nervous because he has been very clear in the past that "people don't wait with this diagnosis," and "you'll be worse next time I see you." He's a very likable person so it's been easy to give him a pass on these kind of messages. After all, he believes them, I'm sure, so who can fault him. 

Yesterday he was wearing a mask, which led us to a discussion that he and his wife are expecting their first and only child. It was fun to celebrate exciting news with him. 

After all the greetings, he started to tell us that he has been running an ongoing clinical trial, investigating a pair of drugs that seem to be well tolerated - better tolerated than the other HDAC inhibitors I've tried. (Like Belinostat and Romedepsin). The two drugs use what they call a "Kick and Kill Strategy," whereby an antiviral medication goes after the Epstein Barr Virus in the tumor, and then kills the tumor. The "kill" strategy is to go after specific mutations such as Row A (classic for AITL) and Tet 2. The HDAC inhibitor in this case is more targeted with less side effects. 

These drugs are taken orally, which is much better than IV, as I've learned. When you do drugs via IV, they come with several other drugs that inhibit allergic reactions and other negative side effects, but that make me feel lousy. 

To qualify, I have to have a tumor (swollen lymph node) greater than 1.5cm and be taking less than 10mg Prednisone daily. I need a new bone marrow biopsy and head CT to make sure the lymphoma has not spread to the bone marrow or brain. I'll have to go to Denver ever 2 weeks and get new PET scans every 2 - 3 months, indefinitely. 

I asked Dr. H if the goal is remission or just management of disease as in the past. He told us of a patient who has been on this regime and essentially in remission for 2 years. They keep wondering if they should keep him on the meds or take him off. Since he is having no side effects, he plans to stay on the drugs for now. 

The drugs are Nanatinostat and Valganciclovir. I will have to go through the evaluation process over the next month or so, between trips, for them to make sure I qualify. 

It sounds promising. 



Comments

Popular posts from this blog

Ya, I'm starting cytotoxic chemo tomorrow.

The good and the bad - accepting both.

Staying flexible and trusting in God's perfect timing